全國服務咨詢熱線：
18860915427
18860915427
產品分類
Product Category詳細介紹
| 品牌 | absin | CAS | 2022-85-7 |
|---|---|---|---|
| 分子式 | C4H4FN3O | 純度 | 99% |
| 分子量 | 129.09 | 貨號 | abs47027430 |
| 規格 | 500mg | 供貨周期 | 現貨 |
| 主要用途 | is a Nucleoside Analog Antifungal | 應用領域 | 化工,生物產業,農林牧漁,制藥/生物制藥,綜合 |
Fluorocytosine 2022-85-7
| 產品描述 | |
| 描述 | Flucytosine is a Nucleoside Analog Antifungal. The chemical classification of flucytosine is Nucleoside Analog. |
| 純度 | 99% |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 5-氟胞mi啶；5-Fluorocytosine；NSC 103805；Ro 2-9915 |
| 外觀 | 白色或類白色結晶性粉末 |
| 可溶性/溶解性 | DMSO : 8 mg/mL (61.97 mM) Water : 5 mg/mL (38.73 mM) |
| 生物活性 | |
| 靶點 | Fungal |
| In vitro(體外研究) | Flucytosine inhibits the growth of C. neoformans in Sabouraud's dextrose broth at concentrations ≥ 1.25 mg/L, and Flucytosine of 50 mg/L causes a ~50% reduction in colony-forming unit (cfu)\ in the J774.16 killing assay with viability of J774.16 cells not affected measured by trypan blue exclusion. The combination of Flucytosine and IgGl monoclonal antibody to Cryptococcus neoformans capsular glucuronoxylomannan is more effective in reducing the numbers of C. neoformans colony-forming units in vitro with J774.16 murine macrophage-like cells than either agent alone. The efficacy of Flucytosine (5FC) in combination with amphotericin B (AB) and fluconazole (FCZ) is studied against 35 yeast isolates, of which the 5FC-FCZ combination is antagonistic against Candida species, but for some Candida isolates synergism is found. |
| In vivo(體內研究) | Administration of Flucytosine in combination with monoclonal antibody 2H1 to A/JCr mice infected with C. neoformans significantly reduces lung but not brain cfu, which is more effective than either agent alone. The combination of intravenous Flucytosine in 0.9% saline (NaCl) and amphotericin B (AmB) provides synergistic antifungal activity and is associated with a lower incidence of nephrotoxicity than with AmB treatment alone. Infusion of Flucytosine (5-10 mg/kg/min) dissolved in 5% glucose into the renal artery of an in situ perfused kidney for 15 minutes increases renal blood flow (RBF) in the rat, and the renal vasodilatation persists for the duration of the Flucytosine infusion. |
| 參考文獻 | |
| 參考文獻 |
|
| 研究領域 | |
| 研究領域 | CancerTumor biomarkers CancerTumor immunology MetabolismTypes of disease Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產品咨詢
電話
微信掃一掃
地址：上海市浦東新區新浩路58號申江科創園18棟
郵箱：fengmj@univ-bio.com
傳真：